Dr Nairobi D Martindale, DO | |
2255 E Mossy Oaks Rd Ste 680, Spring, TX 77389-1812 | |
(281) 537-0300 | |
(281) 537-0315 |
Full Name | Dr Nairobi D Martindale |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 2255 E Mossy Oaks Rd Ste 680, Spring, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144425729 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | BPI10026201 (Texas) | Primary |
Entity Name | Cypress Physicians Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295919223 PECOS PAC ID: 0446272850 Enrollment ID: O20051229000296 |
News Archive
Mondial Assistance and the Computerized Airline Sales and Marketing Association announced today that a fundraiser held during a reception at CASMA's spring conference in Montréal raised enough money to purchase a saturation/end tidal carbon dioxide monitor for the Department of Anesthesia at The Montréal Children's Hospital.
Violence against children in residential institutions can be found across Europe and Central Asia, according to research gathered by UNICEF in the run-up to a major conference on violence against children. The research also reveals glaring gaps in knowledge and data.
Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel.
Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nairobi D Martindale, DO 2255 E Mossy Oaks Rd Ste 680, Spring, TX 77389-1812 Ph: (281) 537-0300 | Dr Nairobi D Martindale, DO 2255 E Mossy Oaks Rd Ste 680, Spring, TX 77389-1812 Ph: (281) 537-0300 |
News Archive
Mondial Assistance and the Computerized Airline Sales and Marketing Association announced today that a fundraiser held during a reception at CASMA's spring conference in Montréal raised enough money to purchase a saturation/end tidal carbon dioxide monitor for the Department of Anesthesia at The Montréal Children's Hospital.
Violence against children in residential institutions can be found across Europe and Central Asia, according to research gathered by UNICEF in the run-up to a major conference on violence against children. The research also reveals glaring gaps in knowledge and data.
Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel.
Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA.
› Verified 9 days ago
Dr. William Min-choy Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8411 Louetta Rd, Spring, TX 77379 Phone: 281-893-5870 Fax: 281-893-5895 | |
Mohammad Nameer Sidiquee, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7105 Fm 2920 Rd, Spring, TX 77379 Phone: 281-737-0902 | |
Dr. Andrew Spafford, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6401 Cypresswood Dr, Suite 180, Spring, TX 77379 Phone: 281-866-7080 Fax: 281-866-7151 | |
Huong T Le, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2306 Rayford Rd, Spring, TX 77386 Phone: 281-453-7777 | |
Randall Feuer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 21301 Kuykendahl Rd, Spring, TX 77379 Phone: 346-336-6904 Fax: 346-336-6910 | |
Marissa Pangan, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3466 Discovery Creek Blvd, Spring, TX 77386 Phone: 281-440-5300 | |
Mrs. Sushma V Gorrela, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6225 Fm 2920 Rd, Suite 100, Spring, TX 77379 Phone: 281-257-5977 Fax: 281-257-5966 |